General Information
Version
1.0
Revision date
2024-02-09
Product name
Aeriol ThixOSYN
1.2.1 Relevant identified uses
Grease multi uses Professional uses
supplier name
Awsum Outcomes Inc
Emergency telephone
1-844-512-4093, +353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
Awsum Outcomes Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info@awsum.global
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction. Causes serious eye irritation
Hazard pictograms
GHS07
Signal word
Warning
Contains
polysulfides, di-tert-dodecyl; benzenesulfonic acid, C10-16-alkyl derivs., calcium salts; benzenesulfonic acid, mono-C16-24-alkyl derivs., calcium salts
Hazard statements
H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.
Precautionary statements
P280 - Wear protective gloves, protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents and container to a collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0.1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. Causes serious eye irritation.
